{"title":"金黄色葡萄球菌菌血症及继发感染的治疗","authors":"Allan G. Jensen MD","doi":"10.1016/S1069-417X(00)80039-4","DOIUrl":null,"url":null,"abstract":"<div><p><em>S. aureus</em> bacteremia is still a serious complication associated with a high mortality. The type of bacteremia is related to outcome and therefore, both the origin of infection and focus identification are highly important for treatment. In general, β-lactam antibiotics or, eventually, vancomycin are still the drugs of choice. The patient should be treated for 2 weeks in uncomplicated <em>S. aureus</em> bacteremia and longer in case of a secondary focus.</p></div>","PeriodicalId":100102,"journal":{"name":"Antimicrobics and Infectious Diseases Newsletter","volume":"18 10","pages":"Pages 73-75"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1069-417X(00)80039-4","citationCount":"1","resultStr":"{\"title\":\"Treatment of Staphylococcus aureus bacteremia and secondary infections\",\"authors\":\"Allan G. Jensen MD\",\"doi\":\"10.1016/S1069-417X(00)80039-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><em>S. aureus</em> bacteremia is still a serious complication associated with a high mortality. The type of bacteremia is related to outcome and therefore, both the origin of infection and focus identification are highly important for treatment. In general, β-lactam antibiotics or, eventually, vancomycin are still the drugs of choice. The patient should be treated for 2 weeks in uncomplicated <em>S. aureus</em> bacteremia and longer in case of a secondary focus.</p></div>\",\"PeriodicalId\":100102,\"journal\":{\"name\":\"Antimicrobics and Infectious Diseases Newsletter\",\"volume\":\"18 10\",\"pages\":\"Pages 73-75\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1069-417X(00)80039-4\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobics and Infectious Diseases Newsletter\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1069417X00800394\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobics and Infectious Diseases Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1069417X00800394","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Treatment of Staphylococcus aureus bacteremia and secondary infections
S. aureus bacteremia is still a serious complication associated with a high mortality. The type of bacteremia is related to outcome and therefore, both the origin of infection and focus identification are highly important for treatment. In general, β-lactam antibiotics or, eventually, vancomycin are still the drugs of choice. The patient should be treated for 2 weeks in uncomplicated S. aureus bacteremia and longer in case of a secondary focus.